Delay in U.S. Telehealth Business Plan and Impairment Loss
First written in FY2016. 1 of 3 entries say "Restated". Latest entry: FY2017.
The whole theme swung hardest in 2017: 4 of 9 companies on the "Worse" side.
5 other companies' latest entry also says "Mitigated".
- FY2017MitigatedAnnual report
「Viterion Corporation, a specified subsidiary, was excluded from the scope of consolidation following completion of the dissolution procedures.」
It states that dissolution procedures for Viterion Corporation, the U.S. telehealth business that recognized impairment in the previous year, have been completed and that the company was excluded from the scope of consolidation. - FY2017-Q3RestatedAnnual report
「In the same period of the previous year, an extraordinary loss was recognized in connection with the impairment of a U.S. sub-subsidiary. However, because no significant extraordinary gains or losses arose in the third quarter under review, quarterly net income attributable to owners of the parent increased 36.4% year on year.」
The impairment related to the U.S. telehealth business in the same period of the previous year is presented as comparative information. No significant extraordinary gains or losses arose in the third quarter under review, and segment information indicates that there was no impairment loss on fixed assets in the current period, but no explicit reduction in the underlying business risk is indicated. - FY2016First statedAnnual report
「In light of the delay in the timing of revenue recognition compared with the plan, the business plan was revised and an impairment test was conducted in accordance with U.S. GAAP. As a result, the entire carrying amounts of goodwill and software assets were impaired.」
An impairment loss of ¥584.331 million was recognized for the telehealth business of U.S.-based Viterion Corporation.